Sandoz Group AG (SWX:SDZ)
Switzerland · Delayed Price · Currency is CHF 68.42
-2.44 (-3.44%)
Oct 1, 2026, 5:30 PM CET
Sandoz Group AG Employees
Sandoz Group AG had 20,000 employees as of June 30, 2026. The number of employees decreased by 2,356 or -10.54% since the number was reported on December 31, 2025.
Employees
20,000
Change
-2,356
Growth
-10.54%
Revenue / Employee
471.71K CHF
Profits / Employee
26.10K CHF
Market Cap
30.66B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 20,000 | -2,356 | -10.54% |
| Dec 31, 2025 | 22,356 | 307 | 1.39% |
| Dec 31, 2024 | 22,049 | -584 | -2.58% |
| Dec 31, 2023 | 22,633 | 895 | 4.12% |
| Dec 31, 2022 | 21,738 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,249 |
| Novartis AG | 75,267 |
| Alcon | 25,000 |
| Lonza Group AG | 20,141 |
| Sonova Holding AG | 18,590 |
| Straumann Holding AG | 11,582 |
| Galderma Group AG | 7,676 |
| Galenica AG | 6,623 |
Sandoz Group AG News
- 7 days ago - GRFS vs. SDZNY: Which Stock Should Value Investors Buy Now? - Nasdaq
- 13 days ago - mAbxience, Sandoz sign collaboration agreement for biosimilar access - TheFly
- 13 days ago - mAbxience and Sandoz Sign a Collaboration Agreement to Advance Biosimilar Access Worldwide - PRNewsWire
- 13 days ago - Sandoz Partners With MAbxience On Hemophilia Biosimilar Program - Nasdaq
- 13 days ago - Sandoz Wins Canadian Marketing Approval For Generic Semaglutide Injection - Nasdaq
- 13 days ago - Sandoz Partners With MAbxience On Emicizumab Biosimilar; Pipeline Reaches 40 Assets - Nasdaq
- 13 days ago - Sandoz Gets Canada Approval for Generic Version of Ozempic - WSJ
- 20 days ago - Sandoz price target raised to CHF 72 from CHF 66 at Berenberg - TheFly